Skip to main content

Table 1 Pharmacokinetic parameters after single administration of Mangiferin calcium salt (MCS) and mangiferin in rats (n = 6)

From: Pharmacokinetic and metabolomic analyses of Mangiferin calcium salt in rat models of type 2 diabetes and non-alcoholic fatty liver disease

Parameters

Mangiferin calcium salt (MCS) (Mean ± SD)

Mangiferin (Mean ± SD)

60 mg/kg

240 mg/kg

960 mg/kg

60 mg/kg

240 mg/kg

960 mg/kg

AUC(0-t)(μg/L·h)

6988.35 ± 1537.44

28,126.50 ± 6750.48*

111,771.00 ± 32,413.59

2200.00 ± 462.89

9187.50 ± 2021.15

37,077.50 ± 11,494.23

AUC(0-∞)(μg/L·h)

7714.49 ± 2005.77

30,981.65 ± 8674.40*

123,314.62 ± 38,227.53

2366.16 ± 567.88

9723.18 ± 2430.80

39,101.95 ± 12,121.60

MRT(0-t)(h)

7.28 ± 1.67

7.27 ± 0.96

7.28 ± 0.98

6.90 ± 1.45

6.89 ± 1.58

6.94 ± 1.87

MRT(0-∞)(h)

9.73 ± 0.98

9.65 ± 0.77

9.71 ± 1.94

8.69 ± 2.17

8.25 ± 2.47

8.21 ± 1.89

T1/2(kα)(h)

1.59 ± 0.13

1.60 ± 0.19

1.57 ± 0.20

1.66 ± 0.22

1.70 ± 0.19

1.72 ± 0.24

T1/2(ke)(h)

3.27 ± 0.52

3.34 ± 0.47

3.36 ± 0.47

3.15 ± 0.41

3.29 ± 0.46

3.30 ± 0.46

Tmax(h)

3.11 ± 0.25

2.99 ± 0.21*

3.06 ± 0.12

4.11 ± 0.33

4.02 ± 0.28

3.97 ± 0.36

Cmax(μg/ml)

0.86 ± 0.21

3.42 ± 0.65*

13.73 ± 3.57

0.28 ± 0.04

1.18 ± 0.28

4.73 ± 1.37

V/F(c) (L/kg)

43.50 ± 8.27

45.11 ± 13.98*

45.54 ± 14.12

134.17 ± 41.59

142.41 ± 41.30

133.34 ± 34.67

CL/F(S)(L/kg·h)

9.23 ± 1.57

9.36 ± 2.53*

9.40 ± 2.54

29.55 ± 7.68

30.05 ± 8.71

28.00 ± 7.12

  1. Compared with mangiferin dosage of 240 mg/kg group, *p < 0.05